Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Barbosa SMB"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-9 z 9
    Tytuł:
    Development of a multivariate predictive model for dapsone adverse drug events in people with leprosy under standard WHO multidrug therapy.
    Autorzy:
    de Araujo ACGDS; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation (INI/Fiocruz), Rio de Janeiro, RJ, Brazil.
    Hacker MAV; Oswaldo Cruz Institute, Oswaldo Cruz Foundation (IOC/Fiocruz), Rio de Janeiro, RJ, Brazil.
    Pinheiro RO; Oswaldo Cruz Institute, Oswaldo Cruz Foundation (IOC/Fiocruz), Rio de Janeiro, RJ, Brazil.
    Illarramendi X; Oswaldo Cruz Institute, Oswaldo Cruz Foundation (IOC/Fiocruz), Rio de Janeiro, RJ, Brazil.
    Durães SMB; Dermatology Department, Fluminense Federal University (UFF), Niterói, RJ, Brazil.
    Nobre ML; Giselda Trigueiro Hospital, Rio Grande do Norte Federal State Public Health department (SESAP-RN), Natal, RN, Brazil.
    Moraes MO; Oswaldo Cruz Institute, Oswaldo Cruz Foundation (IOC/Fiocruz), Rio de Janeiro, RJ, Brazil.
    Sales AM; Oswaldo Cruz Institute, Oswaldo Cruz Foundation (IOC/Fiocruz), Rio de Janeiro, RJ, Brazil.
    da Silva GMS; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation (INI/Fiocruz), Rio de Janeiro, RJ, Brazil.
    Pokaż więcej
    Źródło:
    PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2024 Jan 25; Vol. 18 (1), pp. e0011901. Date of Electronic Publication: 2024 Jan 25 (Print Publication: 2024).
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Leprosy*/drug therapy
    Drug-Related Side Effects and Adverse Reactions*
    Adult ; Humans ; Female ; Dapsone/adverse effects ; Leprostatic Agents/adverse effects ; Rifampin/therapeutic use ; Drug Therapy, Combination ; Case-Control Studies ; Clofazimine/therapeutic use ; Brazil/epidemiology ; World Health Organization
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Gastroenterological Manifestations of Immunoglobulin G Subclass 4-Related Disease-Epidemiology, Clinical Manifestations, Diagnosis and Treatment.
    Autorzy:
    Moreira JLS; School of Medicine, Universidade Federal do Cariri (UFCA), Barbalha 63180-000, CE, Brazil.
    Barbosa SMB; School of Medicine, Universidade Federal do Cariri (UFCA), Barbalha 63180-000, CE, Brazil.
    Meneses PLGM; School of Medicine, Universidade Federal do Cariri (UFCA), Barbalha 63180-000, CE, Brazil.
    Barros PGD; School of Medicine, Universidade Federal do Cariri (UFCA), Barbalha 63180-000, CE, Brazil.
    Lima SSB; School of Medicine, Universidade Federal do Cariri (UFCA), Barbalha 63180-000, CE, Brazil.
    Gomes Junior DM; Programa de Pós-Graduação em Ciências da Saúde, School of Medicine, Universidade Federal do Cariri (UFCA), Barbalha 63180-000, CE, Brazil.
    Leite GMDS; Programa de Pós-Graduação em Ciências da Saúde, School of Medicine, Universidade Federal do Cariri (UFCA), Barbalha 63180-000, CE, Brazil.
    Duarte JO; School of Medicine, Universidade Federal do Cariri (UFCA), Barbalha 63180-000, CE, Brazil.; Programa de Pós-Graduação em Ciências da Saúde, School of Medicine, Universidade Federal do Cariri (UFCA), Barbalha 63180-000, CE, Brazil.
    Alencar Junior GMC; School of Dentistry, CECAPE, Juazeiro do Norte 63024-015, CE, Brazil.
    Almino MAFB; School of Medicine, Universidade Federal do Cariri (UFCA), Barbalha 63180-000, CE, Brazil.; Programa de Pós-Graduação em Ciências da Saúde, Universidade Federal de Sergipe (UFS), Aracaju 49032-490, SE, Brazil.
    Cruz JM; Programa de Pós-Graduação em Biotecnologia em Saúde Humana e Animal, Universidade Estadual do Ceará (UECE), Fortaleza 60356-000, CE, Brazil.
    Batista HMT; School of Medicine, Universidade Federal do Cariri (UFCA), Barbalha 63180-000, CE, Brazil.
    Cândido EL; School of Medicine, Universidade Federal do Cariri (UFCA), Barbalha 63180-000, CE, Brazil.; Programa de Pós-Graduação em Ciências da Saúde, School of Medicine, Universidade Federal do Cariri (UFCA), Barbalha 63180-000, CE, Brazil.
    Oliveira GF; School of Medicine, Universidade Federal do Cariri (UFCA), Barbalha 63180-000, CE, Brazil.
    Cruz HLM; School of Medicine, Universidade Federal do Cariri (UFCA), Barbalha 63180-000, CE, Brazil.
    Gonçalves Júnior J; School of Medicine, Universidade Federal do Cariri (UFCA), Barbalha 63180-000, CE, Brazil.; Department of Rheumatology, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo 01246-903, SP, Brazil.
    Pokaż więcej
    Źródło:
    Life (Basel, Switzerland) [Life (Basel)] 2023 Aug 11; Vol. 13 (8). Date of Electronic Publication: 2023 Aug 11.
    Typ publikacji:
    Journal Article; Review
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Inactivated and Immunogenic SARS-CoV-2 for Safe Use in Immunoassays and as an Immunization Control for Non-Clinical Trials.
    Autorzy:
    Gomes MPB; Virological Technology Laboratory, Bio-Manguinhos/FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.
    Linhares JHR; Virological Technology Laboratory, Bio-Manguinhos/FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.
    Dos Santos TP; Virological Technology Laboratory, Bio-Manguinhos/FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.
    Pereira RC; Virological Technology Laboratory, Bio-Manguinhos/FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.
    Santos RT; Virological Technology Laboratory, Bio-Manguinhos/FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.
    da Silva SA; Virological Technology Laboratory, Bio-Manguinhos/FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.
    Souza MCO; Virological Technology Laboratory, Bio-Manguinhos/FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.
    da Silva JFA; Virological Technology Laboratory, Bio-Manguinhos/FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.
    Trindade GF; Virological Technology Laboratory, Bio-Manguinhos/FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.
    Gomes VS; Virological Technology Laboratory, Bio-Manguinhos/FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.
    Barreto-Vieira DF; Viral Morphology and Morphogenesis Laboratory, Oswaldo Cruz Institute/FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.
    Carvalho MMVF; Immunological Technology Laboratory, Bio-Manguinhos/FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.
    Ano Bom APD; Immunological Technology Laboratory, Bio-Manguinhos/FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.
    Gardinali NR; Virological Technology Laboratory, Bio-Manguinhos/FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.
    Müller R; Pre-Clinical Trials Laboratory, Bio-Manguinhos/FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.
    Alves NDS; Virological Technology Laboratory, Bio-Manguinhos/FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.
    Moura LDC; Virological Technology Laboratory, Bio-Manguinhos/FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.
    Neves PCDC; Immunological Technology Laboratory, Bio-Manguinhos/FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.
    Esteves GS; Recombinant Technology Laboratory, Bio-Manguinhos/FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.
    Schwarcz WD; Virological Technology Laboratory, Bio-Manguinhos/FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.
    Missailidis S; Institute of Technology in Immunobiologicals, Bio-Manguinhos/FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.
    Mendes YDS; Virological Technology Laboratory, Bio-Manguinhos/FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.
    de Lima SMB; Virological Technology Laboratory, Bio-Manguinhos/FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.
    Pokaż więcej
    Źródło:
    Viruses [Viruses] 2023 Jun 30; Vol. 15 (7). Date of Electronic Publication: 2023 Jun 30.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    SARS-CoV-2*
    COVID-19*/prevention & control
    Mice ; Animals ; Antibody Formation ; Antibodies, Viral ; Immunization ; Enzyme-Linked Immunosorbent Assay ; Antibodies, Neutralizing
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Neotropical Sylvatic Mosquitoes and Aedes aegypti Are Not Competent to Transmit 17DD Attenuated Yellow Fever Virus from Vaccinated Viremic New World Non-Human Primates.
    Autorzy:
    de Miranda RM; Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-900, Brazil.
    Fernandes RS; Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-900, Brazil.
    da Silva-Fernandes AT; Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Fundação Oswaldo Cruz, Rio de Janeiro 21040-900, Brazil.
    Ferreira-de-Brito A; Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-900, Brazil.
    Moreira SB; Centro de Primatologia do Rio de Janeiro-CPRJ, Instituto Estadual do Ambiente, Guapimirim 25940-000, Brazil.
    Pereira RC; Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Fundação Oswaldo Cruz, Rio de Janeiro 21040-900, Brazil.
    da Silva Mendes Y; Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Fundação Oswaldo Cruz, Rio de Janeiro 21040-900, Brazil.
    de Lima SMB; Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Fundação Oswaldo Cruz, Rio de Janeiro 21040-900, Brazil.
    Pissinatti A; Centro de Primatologia do Rio de Janeiro-CPRJ, Instituto Estadual do Ambiente, Guapimirim 25940-000, Brazil.
    Freire MDS; Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Fundação Oswaldo Cruz, Rio de Janeiro 21040-900, Brazil.
    Alencar JAF; Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-900, Brazil.
    Lourenco-de-Oliveira R; Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-900, Brazil.
    Pokaż więcej
    Źródło:
    Viruses [Viruses] 2022 Oct 11; Vol. 14 (10). Date of Electronic Publication: 2022 Oct 11.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Aedes*
    Yellow Fever*/prevention & control
    Yellow Fever*/veterinary
    Yellow Fever*/epidemiology
    Leontopithecus*
    Animals ; Humans ; Yellow fever virus ; Mosquito Vectors ; Viremia/prevention & control ; Vaccines, Attenuated ; Primates
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Genetically related genotypes of cowpea present similar bacterial community in the rhizosphere.
    Autorzy:
    de Albuquerque TM; Plant Genetic Resource Group, Agricultural Science Center, Federal University of Piauí, Teresina, PI, Brazil.
    Mendes LW; Center for Nuclear Energy in Agriculture, University of Sao Paulo, Piracicaba, SP, Brazil.
    Rocha SMB; Soil Microbial Ecology Group, Agricultural Science Center, Federal University of Piauí, Teresina, PI, Brazil.
    Antunes JEL; Soil Microbial Ecology Group, Agricultural Science Center, Federal University of Piauí, Teresina, PI, Brazil.
    Oliveira LMS; Soil Microbial Ecology Group, Agricultural Science Center, Federal University of Piauí, Teresina, PI, Brazil.
    Melo VMM; Laboratório de Ecologia Microbiana E Biotecnologia, Federal University of Ceará, Fortaleza, CE, Brazil.
    Oliveira FAS; Laboratório de Ecologia Microbiana E Biotecnologia, Federal University of Ceará, Fortaleza, CE, Brazil.
    Pereira APA; Soil Science Department, Federal University of Ceará, Fortaleza, CE, Brazil.
    da Silva VB; Plant Genetic Resource Group, Agricultural Science Center, Federal University of Piauí, Teresina, PI, Brazil.
    Gomes RLF; Plant Genetic Resource Group, Agricultural Science Center, Federal University of Piauí, Teresina, PI, Brazil.
    de Alcantara Neto F; Plant Genetic Resource Group, Agricultural Science Center, Federal University of Piauí, Teresina, PI, Brazil.
    Lopes ACA; Plant Genetic Resource Group, Agricultural Science Center, Federal University of Piauí, Teresina, PI, Brazil.
    de Moura Rocha M; Embrapa Meio Norte, Teresina, PI, Brazil.
    Araujo ASF; Soil Microbial Ecology Group, Agricultural Science Center, Federal University of Piauí, Teresina, PI, Brazil. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2022 Mar 02; Vol. 12 (1), pp. 3472. Date of Electronic Publication: 2022 Mar 02.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Rhizosphere*
    Vigna*/genetics
    Vigna*/microbiology
    Bacteria/genetics ; Genotype ; Plant Breeding ; Plant Roots/microbiology ; Plants/genetics ; RNA, Ribosomal, 16S/genetics ; Soil Microbiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Safety and immunogenicity of 17DD attenuated yellow fever vaccine in howler monkeys (Alouatta spp.).
    Autorzy:
    Tavares da Silva Fernandes A; Fundação Oswaldo Cruz-Fiocruz, Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Rio de Janeiro, Brazil.
    Moreira SB; Centro de Primatologia do Rio de Janeiro - CPRJ, Instituto Estadual do Ambiente, Guapimirim, Brazil.
    Gaspar LP; Fundação Oswaldo Cruz-Fiocruz, Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Rio de Janeiro, Brazil.
    Simões M; Fundação Oswaldo Cruz-Fiocruz, Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Rio de Janeiro, Brazil.
    Cajaraville ACDRA; Fundação Oswaldo Cruz-Fiocruz, Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Rio de Janeiro, Brazil.
    Pereira RC; Fundação Oswaldo Cruz-Fiocruz, Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Rio de Janeiro, Brazil.
    Gomes MPB; Fundação Oswaldo Cruz-Fiocruz, Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Rio de Janeiro, Brazil.
    Linhares JHR; Fundação Oswaldo Cruz-Fiocruz, Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Rio de Janeiro, Brazil.
    Santos VO; Fundação Oswaldo Cruz-Fiocruz, Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Rio de Janeiro, Brazil.
    Santos RT; Fundação Oswaldo Cruz-Fiocruz, Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Rio de Janeiro, Brazil.
    Amorim JF; Fundação Oswaldo Cruz-Fiocruz, Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Rio de Janeiro, Brazil.
    Barros TADC; Fundação Oswaldo Cruz-Fiocruz, Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Rio de Janeiro, Brazil.
    Melgaço JG; Fundação Oswaldo Cruz-Fiocruz, Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Rio de Janeiro, Brazil.
    da Silva AMV; Fundação Oswaldo Cruz-Fiocruz, Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Rio de Janeiro, Brazil.
    Fernandes CB; Fundação Oswaldo Cruz-Fiocruz, Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Rio de Janeiro, Brazil.
    Tubarão LN; Fundação Oswaldo Cruz-Fiocruz, Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Rio de Janeiro, Brazil.
    da Silva J; Fundação Oswaldo Cruz-Fiocruz, Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Rio de Janeiro, Brazil.
    Caride EC; Fundação Oswaldo Cruz-Fiocruz, Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Rio de Janeiro, Brazil.
    Borges MB; Fundação Oswaldo Cruz-Fiocruz, Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Rio de Janeiro, Brazil.
    Guimarães RC; Fundação Oswaldo Cruz-Fiocruz, Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Rio de Janeiro, Brazil.
    Marchevsky RS; Fundação Oswaldo Cruz-Fiocruz, Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Rio de Janeiro, Brazil.
    de Lima SMB; Fundação Oswaldo Cruz-Fiocruz, Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Rio de Janeiro, Brazil.
    Ano Bom APD; Fundação Oswaldo Cruz-Fiocruz, Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Rio de Janeiro, Brazil.
    Neves PCDC; Fundação Oswaldo Cruz-Fiocruz, Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Rio de Janeiro, Brazil.
    Pissinatti A; Centro de Primatologia do Rio de Janeiro - CPRJ, Instituto Estadual do Ambiente, Guapimirim, Brazil.; Centro Universitário Serra dos Orgãos, Unifeso, Teresópolis, Brazil.
    Freire MDS; Fundação Oswaldo Cruz-Fiocruz, Instituto de Tecnologia em Imunobiológicos/Bio-Manguinhos, Rio de Janeiro, Brazil.
    Pokaż więcej
    Źródło:
    Journal of medical primatology [J Med Primatol] 2021 Feb; Vol. 50 (1), pp. 36-45. Date of Electronic Publication: 2020 Nov 20.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Immunogenicity, Vaccine*
    Alouatta/*immunology
    Yellow Fever Vaccine/*adverse effects
    Animals ; Female ; Male ; Species Specificity ; Vaccines, Attenuated/adverse effects ; Vaccines, Attenuated/immunology ; Yellow Fever Vaccine/immunology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Validation of a yellow fever vaccine model using data from primary vaccination in children and adults, re-vaccination and dose-response in adults and studies with immunocompromised individuals.
    Autorzy:
    Bonin CRB; Institute of Education, Science and Technology of Southeast of Minas Gerais - Cataguases Advanced Campus, Chácara Granjaria, s/n - Granjaria, 36773-563, Cataguases, Brazil. .
    Fernandes GC; Medical School, Presidente Antônio Carlos University, Juiz de Fora, Brazil.
    de Menezes Martins R; Bio-Manguinhos Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.
    Camacho LAB; Sergio Arouca National School of Public Health (ENSP), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.
    Teixeira-Carvalho A; René Rachou Research Center, Oswaldo Cruz Foundation (FIOCRUZ)/Minas, Belo Horizonte, Brazil.
    da Mota LMH; Rheumatology Department, University of Brasilia (UnB), Brasilia, Brazil.
    de Lima SMB; Bio-Manguinhos Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.
    Campi-Azevedo AC; René Rachou Research Center, Oswaldo Cruz Foundation (FIOCRUZ)/Minas, Belo Horizonte, Brazil.
    Martins-Filho OA; René Rachou Research Center, Oswaldo Cruz Foundation (FIOCRUZ)/Minas, Belo Horizonte, Brazil.
    Dos Santos RW; Graduate Program in Computational Modeling, Federal University of Juiz de Fora (UFJF), Juiz de Fora, Brazil.
    Lobosco M; Graduate Program in Computational Modeling, Federal University of Juiz de Fora (UFJF), Juiz de Fora, Brazil.
    Pokaż więcej
    Corporate Authors:
    Collaborative Group for Studies of Yellow Fever Vaccine
    Źródło:
    BMC bioinformatics [BMC Bioinformatics] 2020 Dec 14; Vol. 21 (Suppl 17), pp. 551. Date of Electronic Publication: 2020 Dec 14.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Models, Theoretical*
    Yellow Fever/*prevention & control
    Yellow Fever Vaccine/*immunology
    Adult ; Antibodies, Neutralizing/blood ; Child ; Humans ; Immune System ; Immunization, Secondary ; Immunocompromised Host ; Vaccination ; Yellow Fever/immunology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Low Aedes aegypti Vector Competence for Zika Virus from Viremic Rhesus Macaques.
    Autorzy:
    Fernandes RS; Laboratório de Mosquitos Transmissores de Hematozoários, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-900, Brazil.
    David MR; Laboratório de Mosquitos Transmissores de Hematozoários, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-900, Brazil.
    De Abreu FVS; Laboratório de Mosquitos Transmissores de Hematozoários, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-900, Brazil.
    Ferreira-de-Brito A; Laboratório de Mosquitos Transmissores de Hematozoários, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-900, Brazil.
    Gardinali NR; Laboratório de Desenvolvimento Tecnológico em Virologia, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-900, Brazil.; Laboratório de Tecnologia Imunológica, Instituto de Tecnologia em Imunobiológicos Bio-Manguinhos, Fiocruz, Rio de Janeiro 21040-900, Brazil.
    Lima SMB; Laboratório de Tecnologia Imunológica, Instituto de Tecnologia em Imunobiológicos Bio-Manguinhos, Fiocruz, Rio de Janeiro 21040-900, Brazil.
    Andrade MCR; Serviço de Criação de Primatas não humanos, Instituto de Ciência e Tecnologia em Biomodelos (ICTB), Fiocruz, Rio de Janeiro 21040-900, Brazil.
    Kugelmeier T; Serviço de Criação de Primatas não humanos, Instituto de Ciência e Tecnologia em Biomodelos (ICTB), Fiocruz, Rio de Janeiro 21040-900, Brazil.
    Oliveira JM; Laboratório de Desenvolvimento Tecnológico em Virologia, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-900, Brazil.
    Pinto MA; Laboratório de Desenvolvimento Tecnológico em Virologia, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-900, Brazil.
    Lourenço-de-Oliveira R; Laboratório de Mosquitos Transmissores de Hematozoários, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-900, Brazil.
    Pokaż więcej
    Źródło:
    Viruses [Viruses] 2020 Nov 24; Vol. 12 (12). Date of Electronic Publication: 2020 Nov 24.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Zika Virus*
    Aedes/*virology
    Monkey Diseases/*transmission
    Monkey Diseases/*virology
    Mosquito Vectors/*virology
    Viremia/*virology
    Zika Virus Infection/*veterinary
    Animals ; Female ; Macaca mulatta ; Pregnancy
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Structural investigation of C6/36 and Vero cell cultures infected with a Brazilian Zika virus.
    Autorzy:
    Barreto-Vieira DF; Laboratory of Morphology and Viral Morphogenesis, Instituto Oswaldo Cruz, Fiocruz, Avenida Brasil, Rio de Janeiro, RJ, Brazil.
    Jácome FC; Laboratory of Morphology and Viral Morphogenesis, Instituto Oswaldo Cruz, Fiocruz, Avenida Brasil, Rio de Janeiro, RJ, Brazil.
    da Silva MAN; Laboratory of Morphology and Viral Morphogenesis, Instituto Oswaldo Cruz, Fiocruz, Avenida Brasil, Rio de Janeiro, RJ, Brazil.
    Caldas GC; Laboratory of Morphology and Viral Morphogenesis, Instituto Oswaldo Cruz, Fiocruz, Avenida Brasil, Rio de Janeiro, RJ, Brazil.
    de Filippis AMB; Laboratory of Flavivirus, Instituto Oswaldo Cruz, Fiocruz, Avenida Brasil, Rio de Janeiro, RJ, Brazil.
    de Sequeira PC; Laboratory of Flavivirus, Instituto Oswaldo Cruz, Fiocruz, Avenida Brasil, Rio de Janeiro, RJ, Brazil.
    de Souza EM; Laboratory of Morphology and Viral Morphogenesis, Instituto Oswaldo Cruz, Fiocruz, Avenida Brasil, Rio de Janeiro, RJ, Brazil.
    Andrade AA; Laboratory of Morphology and Viral Morphogenesis, Instituto Oswaldo Cruz, Fiocruz, Avenida Brasil, Rio de Janeiro, RJ, Brazil.
    Manso PPA; Laboratory of Pathology, Instituto Oswaldo Cruz, Fiocruz, Avenida Brasil, Rio de Janeiro, RJ, Brazil.
    Trindade GF; Laboratory of Virological Technology, Bio-Manguinhos, Avenida Brasil, Rio de Janeiro, RJ, Brazil.
    Lima SMB; Laboratory of Virological Technology, Bio-Manguinhos, Avenida Brasil, Rio de Janeiro, RJ, Brazil.
    Barth OM; Laboratory of Morphology and Viral Morphogenesis, Instituto Oswaldo Cruz, Fiocruz, Avenida Brasil, Rio de Janeiro, RJ, Brazil.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2017 Sep 12; Vol. 12 (9), pp. e0184397. Date of Electronic Publication: 2017 Sep 12 (Print Publication: 2017).
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Endoplasmic Reticulum/*ultrastructure
    Lysosomes/*ultrastructure
    Zika Virus/*pathogenicity
    Aedes ; Animals ; Chlorocebus aethiops ; Endoplasmic Reticulum/virology ; Lysosomes/virology ; Vero Cells ; Virus Replication ; Zika Virus/physiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-9 z 9

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies